Pharmacy-Based Infectious Disease Management Programs Incorporating CLIA-Waived Point-of-Care Tests

S R Herbin; D G Klepser; M E Klepser

doi:10.1128/JCM.00726-19

Pharmacy-Based Infectious Disease Management Programs Incorporating CLIA-Waived Point-of-Care Tests

J Clin Microbiol. 2020 Apr 23;58(5):e00726-19. doi: 10.1128/JCM.00726-19. Print 2020 Apr 23.

Authors

S R Herbin¹, D G Klepser², M E Klepser³

Affiliations

¹ College of Pharmacy, Ferris State University, Big Rapids, Michigan, USA.
² College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
³ College of Pharmacy, Ferris State University, Big Rapids, Michigan, USA michaelklepser@ferris.edu.

Abstract

There are roughly 48,000 deaths caused by influenza annually and an estimated 200,000 people who have undiagnosed human immunodeficiency virus (HIV). These are examples of acute and chronic illnesses that can be identified by employing a CLIA-waived test. Pharmacies across the country have been incorporating CLIA-waived point-of-care tests (POCT) into disease screening and management programs offered in the pharmacy. The rationale behind these programs is discussed. Additionally, a summary of clinical data for some of these programs in the infectious disease arena is provided. Finally, we discuss the future potential for CLIA-waived POCT-based programs in community pharmacies.

Keywords: CLIA waived; POCT; pharmacy; point-of-care.

Publication types

Review

MeSH terms

Community Pharmacy Services*
Disease Management
Humans
Pharmacies*
Pharmacy*
Point-of-Care Systems
Point-of-Care Testing